Durhane Wong‐Rieger

1.4k total citations
36 papers, 673 citations indexed

About

Durhane Wong‐Rieger is a scholar working on Economics and Econometrics, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Durhane Wong‐Rieger has authored 36 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 11 papers in Genetics and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Durhane Wong‐Rieger's work include Genomics and Rare Diseases (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Pharmaceutical Economics and Policy (6 papers). Durhane Wong‐Rieger is often cited by papers focused on Genomics and Rare Diseases (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Pharmaceutical Economics and Policy (6 papers). Durhane Wong‐Rieger collaborates with scholars based in Canada, United States and France. Durhane Wong‐Rieger's co-authors include Sharon F. Terry, Donald M. Taylor, Gordon Guyatt, Bartha Maria Knoppers, Kym M. Boycott, Denise Avard, Julie Richer, Erika Kleiderman, Conrad V. Fernandez and Shelin Adam and has published in prestigious journals such as Nature Reviews Drug Discovery, British Journal of Haematology and Atherosclerosis.

In The Last Decade

Durhane Wong‐Rieger

34 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Durhane Wong‐Rieger Canada 15 169 133 126 85 78 36 673
Ryan S. Paquin United States 13 140 0.8× 152 1.1× 58 0.5× 62 0.7× 65 0.8× 36 515
Marleah Dean United States 17 347 2.1× 219 1.6× 33 0.3× 127 1.5× 190 2.4× 53 837
Jan Domaradzki Poland 16 169 1.0× 124 0.9× 52 0.4× 150 1.8× 101 1.3× 75 697
Denise Perry United States 9 253 1.5× 106 0.8× 28 0.2× 151 1.8× 39 0.5× 18 531
Rebecca Moultrie United States 14 85 0.5× 127 1.0× 44 0.3× 157 1.8× 237 3.0× 34 661
Maya Sabatello United States 19 237 1.4× 100 0.8× 62 0.5× 280 3.3× 159 2.0× 70 929
Gemme Campbell‐Salome United States 13 122 0.7× 85 0.6× 46 0.4× 92 1.1× 71 0.9× 38 360
Michael Mendelson United States 16 215 1.3× 60 0.5× 93 0.7× 69 0.8× 49 0.6× 68 1.3k
Silvia Camporesi United Kingdom 14 78 0.5× 236 1.8× 57 0.5× 44 0.5× 65 0.8× 43 678
Alicia C. Staley United States 10 133 0.8× 112 0.8× 32 0.3× 66 0.8× 246 3.2× 13 762

Countries citing papers authored by Durhane Wong‐Rieger

Since Specialization
Citations

This map shows the geographic impact of Durhane Wong‐Rieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Durhane Wong‐Rieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Durhane Wong‐Rieger more than expected).

Fields of papers citing papers by Durhane Wong‐Rieger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Durhane Wong‐Rieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Durhane Wong‐Rieger. The network helps show where Durhane Wong‐Rieger may publish in the future.

Co-authorship network of co-authors of Durhane Wong‐Rieger

This figure shows the co-authorship network connecting the top 25 collaborators of Durhane Wong‐Rieger. A scholar is included among the top collaborators of Durhane Wong‐Rieger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Durhane Wong‐Rieger. Durhane Wong‐Rieger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cam, Yann Le, et al.. (2024). Strengthening health systems for access to gene therapy in rare genetic disorders. Molecular Therapy — Methods & Clinical Development. 32(2). 101220–101220. 2 indexed citations
2.
Currie, Gillian, Diane Lorenzetti, Karen V. MacDonald, et al.. (2023). Developing a Framework of Cost Elements of Socioeconomic Burden of Rare Disease: A Scoping Review. PharmacoEconomics. 41(7). 803–818. 5 indexed citations
3.
Baird, Anne‐Marie, et al.. (2023). How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action. Health Science Reports. 6(6). e1349–e1349. 10 indexed citations
4.
Ward, Leanne M., et al.. (2022). An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries. Orphanet Journal of Rare Diseases. 17(1). 113–113. 14 indexed citations
5.
Gahl, William A., et al.. (2021). Essential list of medicinal products for rare diseases: recommendations from the IRDiRC Rare Disease Treatment Access Working Group. Orphanet Journal of Rare Diseases. 16(1). 308–308. 15 indexed citations
6.
Wong‐Rieger, Durhane, et al.. (2017). Review of 11 national policies for rare diseases in the context of key patient needs. Orphanet Journal of Rare Diseases. 12(1). 63–63. 123 indexed citations
7.
Wong‐Rieger, Durhane. (2017). Moving from Patient Advocacy to Partnership: A Long and Bumpy Road. Patient. 10(3). 271–276. 11 indexed citations
8.
Wood, David, Samira Asma, Douglas Bettcher, et al.. (2017). Global Coalition for the Fight Against Heart Disease and Stroke: A Global Coalition for WHF Second Global Summit on Circulatory Health. Global Heart. 13(1). 37–37.
9.
Elstein, Deborah, et al.. (2016). ASPECTS OF PATIENT REPORTED OUTCOMES IN RARE DISEASES: A DISCUSSION PAPER. International Journal of Technology Assessment in Health Care. 32(3). 126–130. 18 indexed citations
10.
Menon, Devidas, Tania Stafinski, Andrea L. Dunn, & Durhane Wong‐Rieger. (2015). Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle. Patient. 8(1). 103–117. 12 indexed citations
11.
Facey, Karen, Alı́cia Granados, Gordon Guyatt, et al.. (2014). GENERATING HEALTH TECHNOLOGY ASSESSMENT EVIDENCE FOR RARE DISEASES. International Journal of Technology Assessment in Health Care. 30(4). 416–422. 29 indexed citations
12.
Wong‐Rieger, Durhane, et al.. (2014). An Asia Pacific Alliance for Rare Diseases. Patient. 8(1). 11–17. 6 indexed citations
13.
Wong‐Rieger, Durhane, et al.. (2013). Health Coaching in Diabetes: Empowering Patients to Self-Manage. Canadian Journal of Diabetes. 37(1). 41–44. 53 indexed citations
14.
Kleiderman, Erika, Bartha Maria Knoppers, Conrad V. Fernandez, et al.. (2013). Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases. Journal of Medical Ethics. 40(10). 691–696. 65 indexed citations
15.
Wong‐Rieger, Durhane. (2005). Influencing Consumer Cross-Border Internet Pharmacy Shopping Behavior. Journal of Pharmaceutical Marketing & Management. 16(3). 53–62. 1 indexed citations
16.
Teitel, Jerome, et al.. (2004). A review of research related to blood transfusion in Canada, 2000–2002. Transfusion Medicine. 14(3). 195–203. 2 indexed citations
17.
Wong‐Rieger, Durhane. (2004). Influencing Consumer Cross-Border Internet Pharmacy Shopping Behavior. Journal of Pharmaceutical Marketing & Management. 16(3). 53–62. 2 indexed citations
18.
Wong‐Rieger, Durhane, et al.. (1993). Causal evaluation of impact of support workshop for HIV+ men.. PubMed. 84 Suppl 1. S66–70. 2 indexed citations
19.
Wong‐Rieger, Durhane, et al.. (1987). Comparative Acculturation of Southeast Asian and Hispanic Immigrants and Sojourners. Journal of Cross-Cultural Psychology. 18(3). 345–362. 106 indexed citations
20.
Wong‐Rieger, Durhane. (1984). Testing a model of emotional and coping responses to problems in adaptation: Foreign students at a Canadian university. International Journal of Intercultural Relations. 8(2). 153–184. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan S. Paquin Breakdown of academic impact, for papers by Marleah Dean Breakdown of academic impact, for papers by Jan Domaradzki Breakdown of academic impact, for papers by Denise Perry Breakdown of academic impact, for papers by Rebecca Moultrie Breakdown of academic impact, for papers by Maya Sabatello Breakdown of academic impact, for papers by Gemme Campbell‐Salome Breakdown of academic impact, for papers by Michael Mendelson Breakdown of academic impact, for papers by Silvia Camporesi Breakdown of academic impact, for papers by Alicia C. Staley
Rankless by CCL
2026